SavedAdd your journal

Journals / Abant Tıp Dergisi / 2026 / Cilt: 15 Sayı: 2

Machine and Deep Learning Approaches for Migraine Diagnosis and Classification: Advances and Challenges

Rukiye Ölçüoğlu(BAŞKENT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-0429-008X
Muhlis Yiğitcan Dağ(BASKENT UNIVERSITY)0000-0003-0530-863X
Pages
226–238
Publication Date
2026-08-28
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the long term, the integration of such approaches may support earlier and more precise identification of migraine subtypes, guide individualised treatment strategies, and contribute to better patient outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Migraine is a complex neurological disorder characterised by recurrent headaches, sensory disturbances, and autonomic dysfunction.
📊
Key Findings & Data:Despite its high prevalence, accurate diagnosis and effective management remain challenging due to the variability of symptoms and the absence of reliable biomarkers.
💡
Conclusion & Impact:In the long term, the integration of such approaches may support earlier and more precise identification of migraine subtypes, guide individualised treatment strategies, and contribute to better patient outcomes.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Migraine Disorders · Classification · Machine Learning

Abstract

Migraine is a complex neurological disorder characterised by recurrent headaches, sensory disturbances, and autonomic dysfunction. Despite its high prevalence, accurate diagnosis and effective management remain challenging due to the variability of symptoms and the absence of reliable biomarkers. In recent years, approaches based on artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), have offered new perspectives for improving diagnostic accuracy and disease classification. ML models such as support vector machines and random forests have shown potential in identifying neuroimaging and electrophysiological biomarkers, while convolutional neural networks (CNNs) are capable of extracting meaningful patterns from electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) data. Nevertheless, most studies are limited by small, homogeneous datasets and the lack of external validation, which restricts reproducibility and generalisability. Beyond technical performance, the transition of AI tools from research to clinical settings remains constrained by regulatory issues, limited interpretability, and difficulties in integration with existing healthcare systems. Future studies should focus on developing explainable and multimodal frameworks, supported by cross-institutional collaborations and prospective validation, to ensure both methodological robustness and clinical credibility. In the long term, the integration of such approaches may support earlier and more precise identification of migraine subtypes, guide individualised treatment strategies, and contribute to better patient outcomes.

🔖

Cite This Article

Ölçüoğlu, R., Dağ, M. Y. (2026). Machine and Deep Learning Approaches for Migraine Diagnosis and Classification: Advances and Challenges. Abant Tıp Dergisi, Cilt: 15 Sayı: 2, 226–238. https://doi.org/10.47493/abantmedj.1818665

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (87)

  1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1–211.
  2. Goadsby PJ. Mechanisms and management of headache. J R Coll Physicians Lond. 1999;33(3):228–34.
  3. Bigal ME, Borucho S, Serrano D, Lipton RB. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009 Aug;29(8):891–7.
  4. Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, ve ark. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015 Jun;35(7):563–78.
  5. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, ve ark. mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci. 2002 Jun;22(12):5100–7.
  6. De Felice M, Eyde N, Dodick D, Dussor GO, Ossipov MH, Fields HL, ve ark. Capturing the aversive state of cephalic pain preclinically. Ann Neurol. 2013 Aug;74(2):257–65.
  7. Jassar H, Nascimento TD, Kaciroti N, DosSantos MF, Danciu T, Koeppe RA, ve ark. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system. Neuroimage Clin. 2019;23:101905.
  8. DaSilva AF, Nascimento TD, DosSantos MF, Lucas S, van Holsbeeck H, DeBoer M, ve ark. Association of μ-Opioid Activation in the Prefrontal Cortex with Spontaneous Migraine Attacks - Brief Report I. Ann Clin Transl Neurol. 2014 Jun;1(6):439–44.
  9. Cervenka S, Pålhagen SE, Comley RA, Panagiotidis G, Cselényi Z, Matthews JC, ve ark. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006 Aug;129(Pt 8):2017–28.
  10. Scher AI, Ross GW, Sigurdsson S, Garcia M, Gudmundsson LS, Sveinbjörnsdóttir S, ve ark. Midlife migraine and late-life parkinsonism: AGES-Reykjavik study. Neurology. 2014 Sep;83(14):1246–52.
  11. Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, Özge A, ve ark. Migraine: epidemiology and systems of care. Lancet. 2021 Apr;397(10283):1485–95.
  12. Safiri S, Pourfathi H, Eagan A, Mansournia MA, Khodayari MT, Sullman MJM, ve ark. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain. 2022 Feb;163(2):e293–309.
  13. Barral E, Martins Silva E, García-Azorín D, Viana M, Puledda F. Differential Diagnosis of Visual Phenomena Associated with Migraine: Spotlight on Aura and Visual Snow Syndrome. Diagnostics. 2023 Jan;13(2):281.
  14. Hansen JM, Charles A. Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs. J Headache Pain. 2019 Sep;20(1):96.
  15. Khanal S, Underwood M, Naghdi S, Brown A, Duncan C, Matharu M, ve ark. A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine. J Headache Pain. 2022 Sep;23(1):122.
  16. Dodick DW. A Phase-by-Phase Review of Migraine Pathophysiology. Headache. 2018 May;58 Suppl 1:4–16.
  17. Barbanti P, Brighina F, Egeo G, Di Stefano V, Silvestro M, Russo A. Migraine as a Cortical Brain Disorder. Headache. 2020 Oct;60(9):2103–14.
  18. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41(7):638–45.
  19. Russell SJ, Norvig P. Artificial intelligence: a modern approach. 4th ed. Hoboken (NJ): Pearson; 2020.
  20. Park CW, Seo SW, Kang N, Ko B, Choi BW, Park CM, ve ark. Artificial Intelligence in Health Care: Current Applications and Issues. J Korean Med Sci. 2020 Nov;35(42):e379.
  21. Tso AR, Brudfors M, Danno D, Grangeon L, Cheema S, Matharu M, ve ark. Machine phenotyping of cluster headache and its response to verapamil. Brain. 2021 Mar;144(2):655–64.
  22. Sandeep Ganesh G, Kolusu AS, Prasad K, Samudrala PK, Nemmani KVS. Advancing health care via artificial intelligence: From concept to clinic. Eur J Pharmacol. 2022 Nov;934:175320.
  23. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Comput Struct Biotechnol J. 2019;6:94–8.
  24. Jordan MI, Mitchell TM. Machine learning: Trends, perspectives, and prospects. Science. 2015;349(6245):255–60.
  25. Mishra RK, Reddy GYS, Pathak H. The understanding of deep learning: a comprehensive review. Math Probl Eng. 2021;2021:5548884.
  26. Ashraf N, Khan L, Butt S, Chang HT, Sidorov G, Gelbukh A. Multi-label emotion classification of Urdu tweets. PeerJ Comput Sci. 2022;8:e896.
  27. Amjad A, Khan L, Chang HT. Effect on speech emotion classification of a feature selection approach using a convolutional neural network. PeerJ Comput Sci. 2021;7:e766.
  28. Liu F, Bao G, Yan M, Lin G. A decision support system for primary headache developed through machine learning. PeerJ. 2022;10:e12743.
  29. Orrù G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev. 2012 Apr;36(4):1140–52.
  30. O’Muircheartaigh J, Marquand A, Hodkinson DJ, Krause K, Khawaja N, Renton TF, ve ark. Multivariate decoding of cerebral blood flow measures in a clinical model of on-going postsurgical pain. Hum Brain Mapp. 2015 Feb;36(2):633–42.
  31. Pettersson-Yeo W, Benetti S, Marquand AF, Joules R, Catani M, Williams SCR, ve ark. An empirical comparison of different approaches for combining multimodal neuroimaging data with support vector machine. Front Neurosci. 2014;8:189.
  32. Pereira F, Mitchell T, Botvinick M. Machine learning classifiers and fMRI: a tutorial overview. Neuroimage. 2009 Mar;45(1 Suppl):S199-209.
  33. Chong CD, Gaw N, Fu Y, Li J, Wu T, Schwedt TJ. Migraine classification using magnetic resonance imaging resting-state functional connectivity data. Cephalalgia. 2017 Aug;37(9):828–44.
  34. Schwedt TJ, Chong CD, Wu T, Gaw N, Fu Y, Li J. Accurate Classification of Chronic Migraine via Brain Magnetic Resonance Imaging. Headache. 2015 Jun;55(6):762–77.
  35. Schwedt TJ, Si B, Li J, Wu T, Chong CD. Migraine Subclassification via a Data-Driven Automated Approach Using Multimodality Factor Mixture Modeling of Brain Structure Measurements. Headache. 2017 Jul;57(7):1051–64.
  36. Marino S, Jassar H, Kim DJ, Lim M, Nascimento TD, Dinov ID, ve ark. Classifying migraine using PET compressive big data analytics of brain’s μ-opioid and D2/D3 dopamine neurotransmission. Front Pharmacol. 2023;14:1173596.
  37. Vellieux G, Amiel H, Roos C, Crassard I, Houdart E, Kubis N, ve ark. Spectral analysis of EEG in etiological assessment of patients with transient neurological deficits. Neurophysiol Clin. 2021 Jun;51(3):225–32.
  38. Aslan Z. Migraine detection from EEG signals using tunable Q-factor wavelet transform and ensemble learning techniques. Phys Eng Sci Med. 2021 Dec;44(4):1201–12.
  39. Ko HK. Applying machine learning models to diagnosing migraines with EEG diverse algorithms. J Mach Comput. 2024;4(1):170–80.
  40. Awad L, Naffar E, Al-Sharaeh S. Enhancing migraine diagnosis: a symptom-based classification approach with SVM and decision tree. Zenodo [Internet]. 2024 [cited 2026 Jun 23]. Available from: https://doi.org/10.5281/zenodo.10730830
  41. Namitha SJ, Pai P, Kamath P, Madli R. An improved EEG signal feature selection paradigm for migraine detection. J Internet Serv Inf Secur. 2024;14(3):143–56.
  42. Göker H. Automatic detection of migraine disease from EEG signals using bidirectional long short-term memory deep learning model. Signal Image Video Process. 2023;17(4):1255–63.
  43. Halder RK, Uddin MN, Uddin A, Aryal S. Enhancing K‑nearest neighbor algorithm: a comprehensive review and performance analysis of modifications. J Big Data [Internet]. 2024 [cited 2026 Jun 23]. Available from: https://doi.org/10.1186/s40537-024-00973-y
  44. Frid A, Shor M, Shifrin A, Yarnitsky D, Granovsky Y. A Biomarker for Discriminating Between Migraine With and Without Aura: Machine Learning on Functional Connectivity on Resting-State EEGs. Ann Biomed Eng. 2020 Jan;48(1):403–12.
  45. Cao Z, Lai KL, Lin CT, Chuang CH, Chou CC, Wang SJ. Exploring resting-state EEG complexity before migraine attacks. Cephalalgia. 2018 Jun;38(7):1296–306.
  46. Daud SNSS, Sudirman R. Wavelet Based Filters for Artifact Elimination in Electroencephalography Signal: A Review. Ann Biomed Eng. 2022 Oct;50(10):1271–91.
  47. Ferroni P, Zanzotto FM, Scarpato N, Spila A, Fofi L, Egeo G, ve ark. Machine learning approach to predict medication overuse in migraine patients. Comput Struct Biotechnol J. 2020;18:1487–96.
  48. Song XW, Dong ZY, Long XY, Li SF, Zuo XN, Zhu CZ, ve ark. REST: a toolkit for resting-state functional magnetic resonance imaging data processing. PLoS One. 2011;6(9):e25031.
  49. Wang L, Li K, Hu XP. Graph convolutional network for fMRI analysis based on connectivity neighborhood. Netw Neurosci. 2021;5(1):83–95.
  50. Lin K, Jie B, Dong P, Ding X, Bian W, Liu M. Convolutional recurrent neural network for dynamic functional MRI analysis and brain disease identification. Front Neurosci. 2022;16:933660.
  51. Lv H, Wang Z, Tong E, Williams LM, Zaharchuk G, Zeineh M, ve ark. Resting-state functional MRI: everything that nonexperts have always wanted to know. AJNR Am J Neuroradiol. 2018;39(8):1390–9.
  52. Xue T, Yuan K, Cheng P, Zhao L, Zhao L, Yu D, ve ark. Alterations of regional spontaneous neuronal activity and corresponding brain circuit changes during resting state in migraine without aura. NMR Biomed. 2013 Sep;26(9):1051–8.
  53. Yu D, Yuan K, Zhao L, Zhao L, Dong M, Liu P, ve ark. Regional homogeneity abnormalities in patients with interictal migraine without aura: a resting-state study. NMR Biomed. 2012 May;25(5):806–12.
  54. Zhang Q, Wu Q, Zhang J, He L, Huang J, Zhang J, ve ark. Discriminative Analysis of Migraine without Aura: Using Functional and Structural MRI with a Multi-Feature Classification Approach. PLoS One. 2016;11(9):e0163875.
  55. Zhao N, Yue J, Feng ZJ, Qiao Y, Ge Q, Yuan LX, ve ark. The location reliability of the resting-state fMRI functional connectivity of emotional regions towards rTMS therapy. Neuroinformatics. 2022;20(4):1055–64.
  56. Feng ZJ, Deng XP, Zhao N, Jin J, Yue J, Hu YS, ve ark. Resting-state fMRI functional connectivity strength predicts local activity change in the dorsal cingulate cortex: a multi-target focused rTMS study. Cereb Cortex. 2021;32(13):2773–84.
  57. Mao D, Ding Z, Jia W, Liao W, Li X, Huang H, ve ark. Low-frequency fluctuations of the resting brain: high magnitude does not equal high reliability. PLoS One. 2015;10(6):e0128117.
  58. Meszlényi RJ, Hermann P, Buza K, Gál V, Vidnyánszky Z. Resting-state fMRI functional connectivity analysis using dynamic time warping. Front Neurosci. 2017;11:75.
  59. Zhao L, Liu J, Yan X, Dun W, Yang J, Huang L, ve ark. Abnormal brain activity changes in patients with migraine: a short-term longitudinal study. J Clin Neurol. 2014;10(3):229–35.
  60. Liu D, Duan S, Zhang J, Zhou C, Liang M, Yin X, ve ark. Aberrant brain regional homogeneity and functional connectivity in middle-aged T2DM patients: a resting-state functional MRI study. Front Hum Neurosci. 2016;10:490.
  61. Zuo M, Xu Y, Zhang X, Li M, Jia X, Niu J, ve ark. Aberrant brain regional homogeneity and functional connectivity of entorhinal cortex in vascular mild cognitive impairment: a resting-state functional MRI study. Front Neurol. 2019;9:1177.
  62. Blackmon K, Barr WB, Carlson C, Devinsky O, DuBois J, Pogash D, ve ark. Structural evidence for involvement of a left amygdala-orbitofrontal network in subclinical anxiety. Psychiatry Res. 2011;194(3):296–303.
  63. Szegedy C, Liu W, Jia Y, Sermanet P, Reed S, Anguelov D, ve ark. Going deeper with convolutions. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition (CVPR); 2015. p. 1–9.
  64. Dai Z, Yan C, Wang Z, Wang J, Xia M, Li K, ve ark. Discriminative analysis of early Alzheimer’s disease using multi-modal imaging and multi-level characterization with multi-classifier (M3). Neuroimage. 2012 Feb;59(3):2187–95.
  65. Akin M. Comparison of wavelet transform and FFT methods in the analysis of EEG signals. J Med Syst. 2002;26(3):241–7.
  66. Saeidi M, Karwowski W, Farahani FV, Fiok K, Taiar R, Hancock PA, ve ark. Neural Decoding of EEG Signals with Machine Learning: A Systematic Review. Brain Sci. 2021 Nov;11(11):1512.
  67. Datta R, Aguirre GK, Hu S, Detre JA, Cucchiara B. Interictal cortical hyperresponsiveness in migraine is directly related to the presence of aura. Cephalalgia. 2013;33(6):365–74.
  68. Khanna A, Pascual-Leone A, Michel CM, Farzan F. Microstates in resting-state EEG: current status and future directions. Neurosci Biobehav Rev. 2015 Feb;49:105–13.
  69. Zhang X, Zhang X, Huang Q, Chen F. A review of epilepsy detection and prediction methods based on EEG signal processing and deep learning. Front Neurosci. 2024;18:1468967.
  70. Wang YT, Rosa-Neto P, Gauthier S. Advanced brain imaging for the diagnosis of Alzheimer disease. Curr Opin Neurol. 2023 Oct;36(5):481–90.
  71. Yuan H. Toward real-world deployment of machine learning for health care: External validation, continual monitoring, and randomized clinical trials. Health Care Sci. 2024 Oct;3(5):360–4.
  72. Al-Fahoum AS, Al-Fraihat AA. Methods of EEG signal features extraction using linear analysis in frequency and time-frequency domains. ISRN Neurosci. 2014;2014:730218.
  73. Yang H, Zhang J, Liu Q, Wang Y. Multimodal MRI-based classification of migraine: using deep learning convolutional neural network. Biomed Eng Online. 2018 Oct;17(1):138.
  74. Bjørk MH, Stovner LJ, Nilsen BM, Stjern M, Hagen K, Sand T. The occipital alpha rhythm related to the “migraine cycle” and headache burden: a blinded, controlled longitudinal study. Clin Neurophysiol. 2009 Mar;120(3):464–71.
  75. Sakkalis V. Review of advanced techniques for the estimation of brain connectivity measured with EEG/MEG. Comput Biol Med. 2011;41(12):1110–7.
  76. Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019;17(1):1–9.
  77. Parikh RB, Obermeyer Z, Navathe AS. Regulation of predictive analytics in medicine. Science. 2019 Feb;363(6429):810–2.
  78. Gomez-Pilar J, García-Azorín D, Gomez-Lopez-de-San-Roman C, Guerrero ÁL, Hornero R. Exploring EEG Spectral Patterns in Episodic and Chronic Migraine During the Interictal State: Determining Frequencies of Interest in the Resting State. Pain Med. 2020 Dec;21(12):3530–8.
  79. Battineni G, Chintalapudi N, Amenta F. Machine learning driven by magnetic resonance imaging for the classification of Alzheimer disease progression: systematic review and meta-analysis. JMIR Aging. 2024;7:e59370.
  80. Jain A, Bali O, Ritchie N, Singla S. Artificial intelligence in the diagnosis of migraine (with or without aura) in adults: a systematic review. J Indian Acad Clin Med. 2024;25(3):87–99.
  81. Aramruang T, Malhotra A, Numthavaj P, Looareesuwan P. Prediction models for identifying medication overuse or medication overuse headache in migraine patients: a systematic review. J Headache Pain [Internet]. 2024 [cited 2026 Jun 23]. Available from: https://doi.org/10.1186/s10194-024-01874-4
  82. U.S. Food and Drug Administration. Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) [Internet]. Silver Spring (MD): FDA; 2021 [cited 2026 Jun 23]. Available from: https://www.fda.gov/media/145022/download
  83. European Medicines Agency (EMA). Reflection paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle [Internet]. Amsterdam: EMA; 2024 [cited 2026 Jun 23]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf
  84. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019 Oct;366(6464):447–53.
  85. Siddiq M. Integration of machine learning in clinical decision support systems. Eduvest J Univ Stud. 2021;1(12):1579–91.
  86. Eltrafi A, Shrestha S, Ahmed A, Mistry H, Paudyal V, Khanal S. Economic burden of chronic migraine in OECD countries: a systematic review. J Headache Pain. 2023;24(1):45. (Not: Sayfa/makale numarası netleştirilmiştir)
  87. Valliani AA, Ranti D, Oermann EK. Deep Learning and Neurology: A Systematic Review. Neurol Ther. 2019 Dec;8(2):351–65.